DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Japanese startup to develop ultra-compact proton therapy system Designed to replace conventional radiotherapy systems

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

New 12-year study highlights value of PRRT, based on long-term outcomes Understanding peptide receptor radionuclide therapy

RefleXion Medical secures $60 million for approval and launch of BgRT system Can detect and treat multiple tumors in the same session

Radiation oncologists appeal to Congress to safeguard radiotherapy treatment Protecting cancer patients' access to value-based care

Using ERISA to end proton therapy denials Insights from Timothy J. Rozelle and Lisa S. Kantor, from Kantor & Kantor, LLP on getting insurers to provide coverage

Philips unveils IntelliSpace Radiation Oncology system at ESTRO Manages complexity and efficiency of radiology departments

Elekta sues ZAP Surgical Systems, claiming patent infringement Over design and sale of ZAP's radiosurgery platform

Korean cancer center aims to deploy heavy ion therapy in 2022

Thomas Dworetzky , Contributing Reporter
Yonsei Cancer Center in Korea has ambitious plans to take its offerings to the next level, the Center's President Keum Ki-chang told reporters at a news conference at Yonsei University in Shinchon, Seoul.

“Now is the time for quality growth,” he told the assembled reporters according to the Korea Biomedical Review, explaining that present plans call for the unveiling of a heavy ion therapy system in 2022.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



Heavy ion therapy targets tough-to-treat cancers like sarcoma, and those hitting pancreas, lung, and liver. “It will be helpful for tumors that have a high potential for side effects and that are rarely treatable,” Keum noted.

The goal is to make Yonsei a place that “treats and cures cancer well,” he advised, stressing that, “we will not only offer standard therapies but those to treat intractable cancer.”

Yonsei has 13 different cancer centers.

“To advance the cancer hospital, each cancer center should operate innovatively, and the hospital should take responsibility for that. Under this system, I will tear down barriers between departments and grant authority and duty to each center,” he explained.

Plans also call for the onboarding of more CR and MR machines, as well, to cut down on the growing wait times — a byproduct of the rising number of patients using the center.

Its outpatient load has risen at an annual growth rate of 4 percent to 7 percent, up from 490,000 in 2015 to 580,000 in 2018. Inpatient load also grew — rising from 210,000 in 2015 to about 240,000 in 2016, with a ward operation rate that is almost 100 percent.

In March, 2018, Toshiba Energy Systems & Solutions (Toshiba ESS), in consortium with Korea's DK Medical Solutions, was awarded a contract to supply the heavy ion therapy system to Yonsei University Health System.

The system has a horizontally-fixed beam treatment room and two rotating gantry treatment rooms.

Heavy ion therapy generates a carbon ion beam that can travel at about 70 percent of the speed of light and deliver its dose of radiation with pinpoint and lethal accuracy to cancerous tissues and minimum damage to nearby healthy tissue, “with fewer fractions compared to other radiotherapies,” according to a Toshiba statement.

Mamoru Hatazawa, vice president of Toshiba ESS, expressed pride over working with Yonsei University Health System, calling it “the most prestigious hospital in Korea,” and adding that, “I am quite confident that our state-of-the-art heavy ion therapy system will contribute to the advanced radiotherapy in YUHS cancer center.”

The heavy ion therapy is “the most advanced cancer treatment in the world, and will deliver the promise of patient-centered care in an era of incurable cancer and super-aging society,” said Do-Heum Yoon, president and CEO of YUHS.

In October, 2018, Hitachi’s first-ever heavy ion beam therapy system went live at the Osaka Heavy Ion Therapy Center in Japan.

"Heavy ion beam therapy has a higher RBE, particularly at the distal edge of Bragg peak, which may permit greater tumor control," Hiroyuki "Henry" Itami, executive general manager of the radiation oncology system division at Hitachi Ltd., told HCB News at the time. "Also, the smaller lateral penumbra may permit a more conformal dose laterally and limit normal tissue damage. Because heavy ion beam requires a larger accelerator, the size and cost compared with protons can be two to three times greater."

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2019 DOTmed.com, Inc.
版权所有